Evidence map›Paper›PMID 34618242›Full record

ArticleMikrochimica acta2021

Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis.

Alberto Gómez-Caballero, Ainhoa Elejaga-Jimeno, Gontzal García Del Caño, Nora Unceta, Antonio Guerreiro, Miquel Saumell-Esnaola, Joan Sallés, M Aránzazu Goicolea, Ramón J Barrio

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alberto Gómez-CaballeroDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain. a.gomez@ehu.eus.ORCID http://orcid.org/0000-0002-5753-9889
Ainhoa Elejaga-JimenoDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.
Gontzal García Del CañoDepartment of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.ORCID http://orcid.org/0000-0002-7098-0986
Nora UncetaDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.ORCID http://orcid.org/0000-0002-6590-8816
Antonio GuerreiroMIP Diagnostics, Leicester, UK.ORCID http://orcid.org/0000-0002-0068-9704
Miquel Saumell-EsnaolaDepartment of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.
Joan SallésDepartment of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.ORCID http://orcid.org/0000-0001-6727-2674
M Aránzazu GoicoleaDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.ORCID http://orcid.org/0000-0001-8276-2903
Ramón J BarrioDepartment of Analytical Chemistry, University of the Basque Country UPV/EHU, 01006, Vitoria-Gasteiz (Álava), Spain.ORCID http://orcid.org/0000-0002-1685-6685
University of the Basque Country · ES

Funding

departamento de educación, universidades e investigación, gobierno vasco IT1186-19ministerio de ciencia, innovación y universidades CTQ2017-85686-R
6 · The paper itself

Abstract

The production of artificial anti-CB1 antibodies in nanoparticle format is described using the solid-phase imprinting approach. Instead of whole protein imprinting, a linear C-terminus sequence of the receptor comprising 15 amino acids (458-KVTMSVSTDTSAEAL-472) has been used as template, in accordance with the epitope imprinting approach. This sequence is located intracellularly, and it is involved in coupling to G

Indexed as

NanoparticlesReceptor, Cannabinoid, CB1Amino Acid SequenceAntibodiesHumansMolecular ImprintingSolid-Phase Synthesis TechniquesAntibodiesReceptor, Cannabinoid, CB1Artificial antibodyBioanalysisCB1 receptorEpitope imprintingGPCRMolecularly imprinted nanoparticles

Identifiers

PMID34618242
PMCPMC8497319
OpenAlexW3201718002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.